Top Pharmaceuticals companies in Hong Kong by Net Cash Used Provided By Financing Activities
Hong Kong
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 416.48 M
|
Dec. 31, 2023 | USD 14.74 | 7.67% |
|
Hong Kong |
|
| 2 |
USD 48.66 M
|
Dec. 31, 2023 | USD 3.02 | 2.59% |
|
Hong Kong |
|
| 3 |
USD 30.23 M
|
Dec. 31, 2023 | USD 0.21 | 10.11% |
|
Hong Kong |
|
| 4 |
USD 12.91 M
|
Dec. 31, 2023 | USD 0.21 | 8.82% |
|
Hong Kong |
|
| 5 |
USD 11.59 M
|
Dec. 31, 2023 | USD 0.13 | -1.02% |
|
Hong Kong |
|
| 6 |
USD 7.30 M
|
Dec. 31, 2023 | USD 0.10 | 0.02% |
|
Hong Kong |
|
| 7 |
USD 1.72 M
|
Dec. 31, 2023 | USD 0.16 | -0.02% |
|
Hong Kong |
|
| 8 |
USD 884.00 K
|
Dec. 31, 2023 | USD 0.47 | -0.57% |
|
Hong Kong |
|
| 9 |
USD 291.56 K
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
| 10 |
USD 102.28 K
|
June 30, 2024 | USD 4.86 | -4.71% |
|
Hong Kong |
|
| 11 |
USD -4.70 M
|
Dec. 31, 2023 | USD 5.81 | -1.19% |
|
Hong Kong |
|
| 12 |
USD -5.61 M
|
Dec. 31, 2023 | USD 0.39 | 0.30% |
|
Hong Kong |
|
| 13 |
USD -6.27 M
|
Dec. 31, 2023 | USD 0.31 | 0.39% |
|
Hong Kong |
|
| 14 |
USD -11.82 M
|
Dec. 31, 2023 | USD 0.44 | -0.60% |
|
Hong Kong |
|
| 15 |
USD -26.26 M
|
Dec. 31, 2023 | USD 0.18 | -0.02% |
|
Hong Kong |
|
| 16 |
USD -26.92 M
|
March 31, 2024 | USD 0.22 | -1.75% |
|
Hong Kong |
|
| 17 |
USD -31.10 M
|
Dec. 31, 2023 | USD 0.25 | 3.70% |
|
Hong Kong |
|
| 18 |
USD -38.21 M
|
Dec. 31, 2023 | USD 0.49 | 2.14% |
|
Hong Kong |
|
| 19 |
USD -38.99 M
|
Dec. 31, 2023 | USD 0.41 | 1.55% |
|
Hong Kong |
|
| 20 |
USD -41.47 M
|
Dec. 31, 2023 | USD 0.83 | 3.07% |
|
Hong Kong |
|
| 21 |
USD -47.65 M
|
Dec. 31, 2023 | USD 1.04 | 1.48% |
|
Hong Kong |
|
| 22 |
USD -66.55 M
|
March 31, 2024 | USD 0.27 | 0.92% |
|
Hong Kong |
|
| 23 |
USD -82.30 M
|
Dec. 31, 2023 | USD 0.26 | 1.45% |
|
Hong Kong |
|
| 24 |
USD -134.55 M
|
March 31, 2024 | USD 0.13 | 1.98% |
|
Hong Kong |
|
| 25 |
USD -191.93 M
|
Dec. 31, 2023 | USD 1.42 | 0.70% |
|
Hong Kong |
|
| 26 |
USD -274.44 M
|
March 31, 2024 | USD 0.43 | 2.74% |
|
Hong Kong |
|
| 27 |
USD -299.31 M
|
Dec. 31, 2023 | USD 0.91 | -0.72% |
|
Hong Kong |
|
| 28 |
USD -572.60 M
|
Dec. 31, 2023 | USD 0.67 | 1.53% |
|
Hong Kong |
|
| 29 |
USD -922.43 M
|
Dec. 31, 2023 | USD 0.37 | 1.03% |
|
Hong Kong |
Frequently Asked Questions
-
Which Pharmaceuticals company in Hong Kong has the highest Net Cash Used Provided By Financing Activities ?
The Pharmaceuticals company in Hong Kong with the highest Net Cash Used Provided By Financing Activities is BeiGene, Ltd. (HKSE: 6160.HK) at USD 416.48 M.
-
Which Pharmaceuticals company in Hong Kong has the lowest Net Cash Used Provided By Financing Activities ?
The Pharmaceuticals company in Hong Kong with the lowest Net Cash Used Provided By Financing Activities is Sino Biopharmaceutical Limited (HKSE: 1177.HK) at USD -922.43 M.
-
What are the top 10 Pharmaceuticals companies in Hong Kong by Net Cash Used Provided By Financing Activities ?
The top 10 Pharmaceuticals companies in Hong Kong by Net Cash Used Provided By Financing Activities are BeiGene, Ltd., HUTCHMED (China) Limited, Chia Tai Enterprises International Limited, Frontage Holdings Corporation, SinoMab BioScience Limited, Yunnan Energy International Co. Limited, Lee's Pharmaceutical Holdings Limited, OrbusNeich Medical Group Holdings Limited, Dawnrays Pharmaceutical (Holdings) Limited and Regencell Bioscience Holdings Limited.
-
What are the bottom 10 Pharmaceuticals companies in Hong Kong by Net Cash Used Provided By Financing Activities ?
The bottom 10 Pharmaceuticals companies in Hong Kong by Net Cash Used Provided By Financing Activities are Sino Biopharmaceutical Limited, China Resources Pharmaceutical Group Limited, China Medical System Holdings Limited, Alibaba Health Information Technology Limited, The United Laboratories International Holdings Limited, Jacobson Pharma Corporation Limited, China Traditional Chinese Medicine Holdings Co. Limited, Perfect Medical Health Management Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited and Guangdong Hybribio Biotech Co.,Ltd..